Standard Biotools (LAB) Receivables - Other (2021)
Standard Biotools (LAB) posted quarterly Receivables - Other of $2.1 million for Q2 2021, down 25.0% quarter-over-quarter from $2.8 million in Q1 2021.
Standard Biotools (LAB) Receivables - Other (2021) Analysis & Trends
Standard Biotools (LAB) has reported Receivables - Other for 1 consecutive years, with $2.1 million the latest figure, recorded in Q2 2021.
- In Q2 2021, Receivables - Other changed N/A year-over-year to $2.1 million; the TTM figure through Jun 2021 stood at $2.1 million (changed N/A YoY), while the FY2021 annual figure was $2.8 million, changed N/A from the prior year.
- Receivables - Other fell to $2.1 million in Q2 2021 per LAB's latest filing, from $2.8 million in the prior quarter.
- Across five years, Receivables - Other topped out at $2.8 million in Q1 2021 and bottomed at $2.1 million in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Standard Biotools | 250.59 Mn | -226.13 Mn | 10.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 2.10 Mn |
| Jun 30, 2021 | 2.10 Mn |
| Mar 31, 2021 | 2.80 Mn |
| Mar 31, 2021 | 2.80 Mn |